Cogent Biosciences COGT
NASDAQ COGT
$31.02 -0.57 (-1.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Price to Sales (2018 - 2020)

Updated

Cogent Biosciences' (COGT) Price to Sales was 15.81 for Q4 2020, compared with 0.98 a year earlier and up 266.4% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Price to Sales (2018 - 2020) Analysis & Trends

Dating back to Q1 2018, Cogent Biosciences' Price to Sales record includes 12 quarters.

  • By year, Price to Sales came in at 0.98 in FY2019 (-91.3%) and 11.25 in FY2018.
  • The Q4 2020 figure ranks as the highest quarterly Price to Sales since Q3 2018.
  • Year over year, Price to Sales gained in 1 of the last seven quarters, with an average decline of 64.4%.
  • Per Business Quant data, the three quarters before Q4 2020 came in at 4.32 (Q3 2020), 0.60 (Q2 2020) and 0.48 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Cogent Biosciences 5.32 Bn 5.32 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 15.81
Sep 30, 2020 4.32
Jun 30, 2020 0.60
Mar 31, 2020 0.48
Dec 31, 2019 0.98
Sep 30, 2019 4.01
Jun 30, 2019 6.67
Mar 31, 2019 12.51
Dec 31, 2018 11.25
Sep 30, 2018 38.28
Jun 30, 2018 51.39
Mar 31, 2018 12.96
API Access

Cogent Biosciences Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=COGT&period=max&api_key=YOUR_API_KEY